These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10390188)

  • 1. Inhibition of human erythroid colony formation by ceramide.
    Dallalio G; North M; Worden BD; Means RT
    Exp Hematol; 1999 Jul; 27(7):1133-8. PubMed ID: 10390188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human erythroid colony-forming units by interferons alpha and beta: differing mechanisms despite shared receptor.
    Means RT; Krantz SB
    Exp Hematol; 1996 Feb; 24(2):204-8. PubMed ID: 8641342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human erythroid colony-forming units by gamma interferon can be corrected by recombinant human erythropoietin.
    Means RT; Krantz SB
    Blood; 1991 Nov; 78(10):2564-7. PubMed ID: 1824252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of murine erythroid colony formation in vitro by interferon gamma and correction by interferon receptor immunoadhesin.
    Means RT; Krantz SB; Luna J; Marsters SA; Ashkenazi A
    Blood; 1994 Feb; 83(4):911-5. PubMed ID: 8111063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human erythroid colony-forming units by tumor necrosis factor requires beta interferon.
    Means RT; Krantz SB
    J Clin Invest; 1993 Feb; 91(2):416-9. PubMed ID: 8432849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oxidative stress on human erythroid colony formation: Modulation by gamma-interferon.
    Dallalio G; Means RT
    J Lab Clin Med; 2003 Jun; 141(6):395-400. PubMed ID: 12819637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of normal human erythropoiesis by human recombinant DNA-produced alpha-2-interferon in vitro.
    Mamus SW; Oken MM; Zanjani ED
    Exp Hematol; 1986 Dec; 14(11):1015-22. PubMed ID: 3780887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of normal human erythropoiesis by gamma interferon in vitro. Role of monocytes and T lymphocytes.
    Mamus SW; Beck-Schroeder S; Zanjani ED
    J Clin Invest; 1985 May; 75(5):1496-503. PubMed ID: 3923039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingolipid-mediated inflammatory signaling leading to autophagy inhibition converts erythropoiesis to myelopoiesis in human hematopoietic stem/progenitor cells.
    Orsini M; Chateauvieux S; Rhim J; Gaigneaux A; Cheillan D; Christov C; Dicato M; Morceau F; Diederich M
    Cell Death Differ; 2019 Sep; 26(9):1796-1812. PubMed ID: 30546074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human erythroid colony-forming units by interleukin-1 is mediated by gamma interferon.
    Means RT; Dessypris EN; Krantz SB
    J Cell Physiol; 1992 Jan; 150(1):59-64. PubMed ID: 1730787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulatory effect of human insulin on erythroid progenitors (CFU-E and BFU-E) in human CD34+ separated bone marrow cells and the relationship between insulin and erythropoietin.
    Aoki I; Taniyama M; Toyama K; Homori M; Ishikawa K
    Stem Cells; 1994 May; 12(3):329-38. PubMed ID: 7521243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of CFU-E colony formation in uremic patients with inflammatory disease: role of IFN-gamma and TNF-alpha.
    Allen DA; Breen C; Yaqoob MM; Macdougall IC
    J Investig Med; 1999 May; 47(5):204-11. PubMed ID: 10361379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
    Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
    Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
    J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of erythropoiesis and myelopoiesis by exogenous erythropoietin in human long-term marrow cultures.
    Mayani H; Guilbert LJ; Janowska-Wieczorek A
    Exp Hematol; 1990 Mar; 18(3):174-9. PubMed ID: 2303109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-alpha inhibits generation of glycophorin A+ cells by CD34+ cells.
    Xiao W; Koizumi K; Nishio M; Endo T; Osawa M; Fujimoto K; Sato I; Sakai T; Koike T; Sawada Ki
    Exp Hematol; 2002 Nov; 30(11):1238-47. PubMed ID: 12423676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine-1-phosphate is a mediator of TNF-α action on the Na+/K+ ATPase in HepG2 cells.
    Dakroub Z; Kreydiyyeh SI
    J Cell Biochem; 2012 Jun; 113(6):2077-85. PubMed ID: 22271589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingomyelinase and ceramide inhibit formation of F-actin ring in and bone resorption by rabbit mature osteoclasts.
    Takeda H; Ozaki K; Yasuda H; Ishida M; Kitano S; Hanazawa S
    FEBS Lett; 1998 Jan; 422(2):255-8. PubMed ID: 9490019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. R-h-erythropoietin counteracts the inhibition of in vitro erythropoiesis by tumour necrosis factor alpha in patients with rheumatoid arthritis.
    Jongen-Lavrencic M; Peeters HR; Backx B; Touw IP; Vreugdenhil G; Swaak AJ
    Rheumatol Int; 1994; 14(3):109-13. PubMed ID: 7839070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.